Edgen Stock·Oct 02 2025, 13:39戻る
戻る
AngioDynamics Exceeds Q1 Revenue Estimates Amidst Narrower Loss
Edgen Stock·Oct 02 2025, 13:39
[1] AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates (https://finance.yahoo.com/news/angiodynamics- ...)[2] AngioDynamics Reports Fiscal Year 2026 First Quarter Financial Results; Med Tech Growth of 26.1% Drives Continued Momentum - Stock Titan (https://vertexaisearch.cloud.google.com/groun ...)[3] Zacks Investment Research: Stock Research, Analysis, & Recommendations (https://vertexaisearch.cloud.google.com/groun ...)